## [Anaesthesia Primary Exam](https://ketaminenightmares.com/pex)

### Pharmacology SAQ

#### Intravenous anaesthetics

- [1999A16 Alpha 2 adrenoceptoragonists](1999A16_alpha_2_adrenoceptor_agonists.htm)
- [2002A11 Thiopentone and ketamine non-CNS effects](2002A11_thiopentone_and_ketamine_non_cns_effects.htm)
- [2002A16 Flumazenil](2002A16_flumazenil.htm)
- [2003B06 Alpha 2 adrenoceptor agonists - limitations of clonidine](2003B06_alpha_2_adrenoceptor_agonists_and_limitations_of_clonidine.htm)
- [2004B07 Propofol - inter-individual variation in elimination half life](2004B07_propofol_inter_individual_variation_in_elimination_half_life.htm)
- [2006B03 Intravenous induction inter individual variation](2006B03_intravenous_induction_inter_individual_variation.htm)
- [2007A04 Propofol TIVA vs ketamine TIVA](2007A04_propofol_tiva_vs_ketamine_tiva.htm)
- [2008A03 Ideal sedative](2008A03_ideal_sedative.htm)
- [2008B02 Propofol TIVA](2008B02_propofol_tiva.htm)
- [2008B03 Clonidine](2008B03_clonidine.htm)
- [2009B02 Propofol adverse effects](2009B02_propofol_adverse_effects.htm)
- [2012A07 Ketamine TIVA](2012A07_ketamine_tiva.htm)
- [2012B02 Propofol vs sevoflurane - kinetics, CVS, CNS](2012B02_propofol_vs_sevoflurane_kinetics_cvs_and_cns_effects.htm)
- [2017B14 Propofol - non-CNS effects](2017B14_propofol_non_cns_effects.htm)
- [2018A07 Intravenous induction dosing - youth, old, age and shock](2018A07_intravenous_induction_dosing_in_youth_old_age_and_shock.htm)
- [2018B11 Midazolam](2018B11_midazolam.htm)
- [2019A11 Propofol TCI](2019A11_propofol_tci.htm)
- [2020A13 Intravenous induction rate of onset](2020A13_intravenous_induction_rate_of_onset.htm)
- [2021A02 Propofol vs sevoflurane - neurophysiology](2021A02_propofol_sevoflurane_neurophysiology.htm)
- [2021B04 Dexmedetomidine](2021B04_dexmedetomidine.htm)
- [2021B15 Propofol - time to emergence](2021B15_propofol_time_to_emergence.htm)
